×

ImmunityBio Trying To Find Solid Ground

Losses Pile Up

ImmunityBio’s latest Securities and Exchange Commission filings show a company still working to establish profitable operations while shining a light on the company’s purchase of…

Starting at $3.50/week.

Subscribe Today